| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 葵花药业集团股份有限公司是以“勇担祖国中药传承光大的历史责任，做传统现代中药的领航者、精品儿药的领军者”为使命，以品牌OTC产品为核心，覆盖研发、生产和销售全产业链的知名医药企业。 集团前身是原黑龙江省国有五常制药厂，1998年改制为民营企业——黑龙江葵花药业股份有限公司，随后不断发展壮大，于2005年组建葵花药业集团股份有限公司。集团现下辖12家药品制造企业、6家销售公司、4家药物研究院、2家药材种植基地、1家药品包材公司等30余家子公司，总部位于哈尔滨市。 2014年底在深圳上市，股票代码：002737。 | ||||||||||||||||||||||||
| Main Business | 各类中成药、化学药品（包括生物制药）、健康养生品的研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | 关玉秀 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 周广阔 | ||||||||||||||||||||||||
| Solicitors | 北京市天元律师事务所 | ||||||||||||||||||||||||
| Auditors | 瑞华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0451-82307136 | ||||||||||||||||||||||||
| Fax No | 0451-82367253 | ||||||||||||||||||||||||
| Website | www.kuihuayaoye.com | ||||||||||||||||||||||||
| 3124893@qq.com;2101474806@qq.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 30/12/2014 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.440 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.200 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 6.572 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 7.721B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |